At least 12 new advanced therapy medicinal products (ATMPs) are expected to get market approval in either the US or the EU over the next 18 months, and there are hundreds more in the pipeline, but a lot needs to be done to prepare healthcare systems for the routine, systematic uptake of these therapies.
There is no doubt that healthcare providers recognize the “remarkable" value of these therapies and "we have had some pretty...